Poster nominee oral presentations
Wednesday, March 21st
Time: 14:00 - 15:30
Room: Amber 1
Facilitators: Helena Jenzer, Gunar Stemer, André Rieutord, Nicoletta Ambrogi
|
|
Poster nominee oral presentations |
Authors |
|
|
|
|
|
|
||
| PHC006 |
Behind CYP450 interaction tables – the effect of gender and age on pharmacokinetics |
Sadeghi, L. |
|
|
| PHC007 |
Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment |
Swen, J. |
|
|
| CPC012 |
Development and evaluation of a ward-based clinical pharmacy service on a neonatal intensive care unit (NICU) |
Conway, C. |
|
|
| TCH015 |
Effect of bar-code technology on the safety of cytostaic drugs administration |
Serrano Vicente, M. |
|
|
| CPC057 |
Self-administered home parenteral antibiotic treatment using elastomeric infusion pumps in orthopaedic patients |
Omestad, H. |
|
Thursday, March 22nd
Time: 8:30 - 10:00
Room: Amber 1
Facilitators: Helena Junker, Gunar Stemer, André Rieutord, Nicoletta Ambrogi
|
|
Poster nominee oral presentations |
Authors |
|
|
|
|
|
| TCH023 |
Evaluation of surface contamination with eight antineoplastic drugs in preparation and administration areas in Polish hospitals |
Korczowska, E. |
|
|
|
|
|
| PHC023 |
Are the official recommendations for amikacine serum levels suitable |
Lajoinie, A. |
|||||
| OHP031 |
Designing and implementing a standard nutritional starter solution for preterm infants |
Marquinez Alonso, I. |
|
|
|
|
|
| GRP094 |
Prevention of medication errors: an observational study |
El Hilali Maso, N. |
|
|
|
|
|
| TCH034 |
Proteomic approach to investigating the molecular integrity of infliximab after reconstitution and dilution in typical hospital conditions |
Antonio, S. |
|
|
|
|
|
| GRP104 |
Closing the gap – improving patient safety with better drug information |
Mildner, C. |
|
|
|
|
